ABC | Volume 113, Nº2, August 2019

Original Article Kul et al PSW and type 2 DM Arq Bras Cardiol. 2019; 113(2):207-215 This is an open-access article distributed under the terms of the Creative Commons Attribution License 23. Akyüz AR, Turan T, Gürbak İ, Korkmaz L, Ağaç MT, Çelik Ş. The relationship between presystolic wave and subclinical left ventricular dysfunction in asymptomatic hypertensive patients. Blood Press Monit. 2016;21(5):277-81. 24. American Diabetes Association. [Cited in 25 Dec 2013] Diabetes statistics. 2011. Available from [www.diabetes.org/diabetes-basics/ diabetes-statistics/] 25. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595–602. 26. de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Barac A, et al. Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens. 2010;28(2):353–60. 27. Litwin SE. Diabetes and the heart: is there objective evidence of a human diabetic cardiomyopathy? Diabetes. 2013;62(10):3329–30. 28. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597–605. 29. Norton GR, Candy G, Woodiwiss AJ. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation. 1996; 93(10):1905–12. 30. Singh R, Barden A, Mori T, Beilin L. Advanced glycation endproducts: a review. Diabetologia. 2001;44(2):129-46. 31. StahrenbergR,EdelmannF,MendeM,KockskämperA,DüngenHD,Scherer M, et al. Association of glucosemetabolismwith diastolic function along the diabetic continuum. Diabetologia. 2010;53(7):1331-40. 32. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemiainduced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938-48. 33. Bojunga J, Nowak D, Mitrou PS, Hoelzer D, Zeuzem S, Chow KU. Antioxidative treatment prevents activation of death-receptorand mitochondrion-dependent apoptosis in the hearts of diabetic rats. Diabetologia. 2004;47(12):2072-80. 34. Harada K, Tamura M, Toyono M, Oyama K, Takada G. Assessment of global left ventricular function by tissue Doppler imaging. Am J Cardiol. 2001;88(8):927–32, A9. 35. Adar A, Kırış A, Bülbül Y, Bektaş H, Acat M, Casim H, et al. Association of fragmentedQRSwith subclinical left ventricular dysfunction in patients with obstructive sleep apnea. Med Princ Pract. 2015;24(4):376–81. 36. Karatzis EN, Giannakopoulou AT, Papadakis JE, Karazachos AV, Nearchou NS. Myocardial performance index (Tei index): evaluating its application to myocardial infarction. Hellenic J Cardiol. 2009;50(1):60–5. 37. Tei C, Ling LH, HodgeDO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26(6):357–66. 215